BPY2C

Q-omics provides the consensus-scored BPY2C profile across patient tissues and cancer cell-line models. BPY2C expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, BPY2C RNA expression shows 113 significant protein co-abundance associations, with the highest sampling consensus in CCRCC. Together, these results highlight STAD, and CCRCC as cancer lineages where BPY2C shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes BPY2C survival associations across molecular data types. BPY2C RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

BPY2C data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	STAD (72)	view →

This table ranks reproducible BPY2C RNA expression–survival associations across cancer types. High BPY2C expression shows unfavorable associations in STAD and KIRC. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for BPY2C RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.126	0.677	<.001	72	view →
KIRC	OS	Tertile	II,III,IV	0.134	0.717	.018	54	view →

Pink = unfavorable, green = favorable. all 2 lineages →

BPY2C-STAD (OS)

Explore this curve interactively →